# Coherus Oncology, Inc. > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:6619bbc6-5811-4bdc-9397-824acc3e1242 | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/coherus-oncology-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 16 | | Claims under review | 1 | | Evidence records | 4 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-19T14:44:51.089262+00:00 | | Last reviewed | 2026-10-19T14:44:51.089262+00:00 | ## Identity - Legal name: Coherus Oncology, Inc. - Display name: Coherus Oncology, Inc. ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-19T22:39:35.279188+00:00 | | Completeness | 0.409 | | Record Quality | 0.822 | | Directors | 9 | | Committees | 1 | | Governance events | 7 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Charles W. Newton: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2022-01-01. claim_id=alpha:claim:company:6619bbc6-5811-4bdc-9397-824acc3e1242:leadership_role:7 - Georgia Erbez: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2024-01-01. claim_id=alpha:claim:company:6619bbc6-5811-4bdc-9397-824acc3e1242:leadership_role:8 - Jill O’Donnell-Tormey: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2022-01-01. claim_id=alpha:claim:company:6619bbc6-5811-4bdc-9397-824acc3e1242:leadership_role:9 - Lee N. Newcomer: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2022-01-01. claim_id=alpha:claim:company:6619bbc6-5811-4bdc-9397-824acc3e1242:leadership_role:10 - Mats L. Wahlström: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2012-01-01. claim_id=alpha:claim:company:6619bbc6-5811-4bdc-9397-824acc3e1242:leadership_role:11 - Michael Ryan: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2023-01-01. claim_id=alpha:claim:company:6619bbc6-5811-4bdc-9397-824acc3e1242:leadership_role:12 - Rita A. Karachun: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2024-01-01. claim_id=alpha:claim:company:6619bbc6-5811-4bdc-9397-824acc3e1242:leadership_role:13 - Ali J. Satvat: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:6619bbc6-5811-4bdc-9397-824acc3e1242:leadership_role:6 - Dennis M. Lanfear: President, Chief Executive Officer and Chairman of the Board. Status: unknown. Independent: false. Since: NOT_PUBLISHED. Committees: Chief Executive Officer and Chairman of the Board (member). claim_id=alpha:claim:company:6619bbc6-5811-4bdc-9397-824acc3e1242:leadership_role:5 ## Committees - Chief Executive Officer and Chairman of the Board (executive). Chair: NOT_PUBLISHED. Members: Dennis M. Lanfear (member, unknown). committee_id=alpha:committee:coherus-oncology-inc:chief-executive-officer-and-chairman-of-the-board ## Executive leadership - Bryan McMichael: Chief Financial Officer [CFO]. Status: unknown. claim_id=alpha:claim:company:6619bbc6-5811-4bdc-9397-824acc3e1242:leadership_role:14 - Dennis M. Lanfear: President and Chief Executive Officer [CEO]. Status: unknown. claim_id=alpha:claim:company:6619bbc6-5811-4bdc-9397-824acc3e1242:leadership_role:15 - Paul Reider: Chief Commercial Officer. Status: unknown. claim_id=alpha:claim:company:6619bbc6-5811-4bdc-9397-824acc3e1242:leadership_role:16 ## Governance events - DIRECTOR_APPOINTED: Georgia Erbez seat on Coherus Oncology, Inc., effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-19T14:44:51.089262+00:00. event_id=alpha:event:transition:126yukw1x9g864 - DIRECTOR_APPOINTED: Rita A. Karachun seat on Coherus Oncology, Inc., effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-19T14:44:51.089262+00:00. event_id=alpha:event:transition:zq19kq1cf0m7y - DIRECTOR_APPOINTED: Michael Ryan seat on Coherus Oncology, Inc., effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-19T14:44:51.089262+00:00. event_id=alpha:event:transition:80j54eqsbq38 - DIRECTOR_APPOINTED: Charles W. Newton seat on Coherus Oncology, Inc., effective 2022-01-01. Effective: 2022-01-01. Detected: 2026-10-19T14:44:51.089262+00:00. event_id=alpha:event:transition:t671fx1jjb479 - DIRECTOR_APPOINTED: Jill O’Donnell-Tormey seat on Coherus Oncology, Inc., effective 2022-01-01. Effective: 2022-01-01. Detected: 2026-10-19T14:44:51.089262+00:00. event_id=alpha:event:transition:1xzxkg9y5jyyn - DIRECTOR_APPOINTED: Lee N. Newcomer seat on Coherus Oncology, Inc., effective 2022-01-01. Effective: 2022-01-01. Detected: 2026-10-19T14:44:51.089262+00:00. event_id=alpha:event:transition:1mg4knj1e8vezf - DIRECTOR_APPOINTED: Mats L. Wahlström seat on Coherus Oncology, Inc., effective 2012-01-01. Effective: 2012-01-01. Detected: 2026-10-19T14:44:51.089262+00:00. event_id=alpha:event:transition:11th9nvpxddm5 ## Scoped resources - `alpha://company/coherus-oncology-inc` (contract): https://registry.alpha.ac/api/public/companies/coherus-oncology-inc?format=record - `alpha://company/coherus-oncology-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/coherus-oncology-inc?format=record§ion=identity - `alpha://company/coherus-oncology-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/coherus-oncology-inc?format=record§ion=corporate-structure - `alpha://company/coherus-oncology-inc/board` (contract): https://registry.alpha.ac/api/public/companies/coherus-oncology-inc?format=record§ion=board - `alpha://company/coherus-oncology-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/coherus-oncology-inc?format=record§ion=committees - `alpha://company/coherus-oncology-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/coherus-oncology-inc?format=record§ion=leadership - `alpha://company/coherus-oncology-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/coherus-oncology-inc?format=record§ion=ownership - `alpha://company/coherus-oncology-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/coherus-oncology-inc?format=record§ion=financials - `alpha://company/coherus-oncology-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/coherus-oncology-inc?format=record§ion=capital-structure - `alpha://company/coherus-oncology-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/coherus-oncology-inc?format=record§ion=compensation - `alpha://company/coherus-oncology-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/coherus-oncology-inc?format=record§ion=governance - `alpha://company/coherus-oncology-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/coherus-oncology-inc?format=record§ion=shareholder-governance - `alpha://company/coherus-oncology-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/coherus-oncology-inc?format=record§ion=audit - `alpha://company/coherus-oncology-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/coherus-oncology-inc?format=record§ion=legal - `alpha://company/coherus-oncology-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/coherus-oncology-inc?format=record§ion=risk - `alpha://company/coherus-oncology-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/coherus-oncology-inc?format=record§ion=cyber - `alpha://company/coherus-oncology-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/coherus-oncology-inc?format=record§ion=ai-governance - `alpha://company/coherus-oncology-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/coherus-oncology-inc?format=record§ion=agents - `alpha://company/coherus-oncology-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/coherus-oncology-inc?format=record§ion=ecosystem - `alpha://company/coherus-oncology-inc/events` (contract): https://registry.alpha.ac/api/public/companies/coherus-oncology-inc?format=record§ion=events - `alpha://company/coherus-oncology-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/coherus-oncology-inc?format=record§ion=relationships - `alpha://company/coherus-oncology-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/coherus-oncology-inc?format=record§ion=assessments - `alpha://company/coherus-oncology-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/coherus-oncology-inc?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - NO_RECORDS_FOUND ## Leadership - Dennis M. Lanfear: President, Chief Executive Officer and Chairman of the Board. Claim: alpha:claim:company:6619bbc6-5811-4bdc-9397-824acc3e1242:leadership_role:5. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:6c87b1d4cb99ce34dd137cb65e2fe392bf76f7ec0e95baea717e4271336af72b. - Ali J. Satvat: Director. Claim: alpha:claim:company:6619bbc6-5811-4bdc-9397-824acc3e1242:leadership_role:6. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:6c87b1d4cb99ce34dd137cb65e2fe392bf76f7ec0e95baea717e4271336af72b. - Charles W. Newton: Director. Claim: alpha:claim:company:6619bbc6-5811-4bdc-9397-824acc3e1242:leadership_role:7. Valid from: 2022-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:02f2472e431b1f11e2f74d6011fb22527d8384b52faaee0a569c9fd843bc5fba. - Georgia Erbez: Director. Claim: alpha:claim:company:6619bbc6-5811-4bdc-9397-824acc3e1242:leadership_role:8. Valid from: 2024-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:02f2472e431b1f11e2f74d6011fb22527d8384b52faaee0a569c9fd843bc5fba. - Jill O’Donnell-Tormey: Director. Claim: alpha:claim:company:6619bbc6-5811-4bdc-9397-824acc3e1242:leadership_role:9. Valid from: 2022-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:02f2472e431b1f11e2f74d6011fb22527d8384b52faaee0a569c9fd843bc5fba. - Lee N. Newcomer: Director. Claim: alpha:claim:company:6619bbc6-5811-4bdc-9397-824acc3e1242:leadership_role:10. Valid from: 2022-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:02f2472e431b1f11e2f74d6011fb22527d8384b52faaee0a569c9fd843bc5fba. - Mats L. Wahlström: Director. Claim: alpha:claim:company:6619bbc6-5811-4bdc-9397-824acc3e1242:leadership_role:11. Valid from: 2012-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:02f2472e431b1f11e2f74d6011fb22527d8384b52faaee0a569c9fd843bc5fba. - Michael Ryan: Director. Claim: alpha:claim:company:6619bbc6-5811-4bdc-9397-824acc3e1242:leadership_role:12. Valid from: 2023-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:02f2472e431b1f11e2f74d6011fb22527d8384b52faaee0a569c9fd843bc5fba. - Rita A. Karachun: Director. Claim: alpha:claim:company:6619bbc6-5811-4bdc-9397-824acc3e1242:leadership_role:13. Valid from: 2024-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:02f2472e431b1f11e2f74d6011fb22527d8384b52faaee0a569c9fd843bc5fba. - Bryan McMichael: Chief Financial Officer. Claim: alpha:claim:company:6619bbc6-5811-4bdc-9397-824acc3e1242:leadership_role:14. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:6c87b1d4cb99ce34dd137cb65e2fe392bf76f7ec0e95baea717e4271336af72b. - Dennis M. Lanfear: President and Chief Executive Officer. Claim: alpha:claim:company:6619bbc6-5811-4bdc-9397-824acc3e1242:leadership_role:15. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:6c87b1d4cb99ce34dd137cb65e2fe392bf76f7ec0e95baea717e4271336af72b. - Paul Reider: Chief Commercial Officer. Claim: alpha:claim:company:6619bbc6-5811-4bdc-9397-824acc3e1242:leadership_role:16. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f0034a9d4b11be7fe757ced4c71f20a26060be745a9547fd244e5f1d483516b6. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - PUBLISHED ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - Coherus Oncology, Inc.. Claim: alpha:claim:company:6619bbc6-5811-4bdc-9397-824acc3e1242:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:6487fdb1a281a38250a02c6610753ec9707cb1b479e0cbecf1929f2e9353c0fd. ## Entity Status - Public listing published. Claim: alpha:claim:company:6619bbc6-5811-4bdc-9397-824acc3e1242:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:6487fdb1a281a38250a02c6610753ec9707cb1b479e0cbecf1929f2e9353c0fd. ## Published Fact - US. Claim: alpha:claim:company:6619bbc6-5811-4bdc-9397-824acc3e1242:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:6487fdb1a281a38250a02c6610753ec9707cb1b479e0cbecf1929f2e9353c0fd. ## Security Listing - CHRS (NASDAQ). Claim: alpha:claim:company:6619bbc6-5811-4bdc-9397-824acc3e1242:security_listing:17. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:6487fdb1a281a38250a02c6610753ec9707cb1b479e0cbecf1929f2e9353c0fd. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:6487fdb1a281a38250a02c6610753ec9707cb1b479e0cbecf1929f2e9353c0fd: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/coherus-oncology-inc). - alpha:projection-evidence:document:6c87b1d4cb99ce34dd137cb65e2fe392bf76f7ec0e95baea717e4271336af72b: [SEC DEF 14A 0001104659-26-045251](https://www.sec.gov/Archives/edgar/data/1512762/000110465926045251/chrs-20260527xdef14a.htm). - alpha:projection-evidence:document:02f2472e431b1f11e2f74d6011fb22527d8384b52faaee0a569c9fd843bc5fba: [DEF 14A chrs-20260527xdef14a.htm](https://www.sec.gov/Archives/edgar/data/1512762/000110465926045251/chrs-20260527xdef14a.htm). - alpha:projection-evidence:document:f0034a9d4b11be7fe757ced4c71f20a26060be745a9547fd244e5f1d483516b6: CHRS executive roster source. ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/coherus-oncology-inc) - [Public Markdown](https://registry.alpha.ac/companies/coherus-oncology-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/coherus-oncology-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/coherus-oncology-inc?format=jsonld) - MCP resource: `alpha://companies/coherus-oncology-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage. ## Critical-risk oversight Snapshot as of 2026-10-19T22:39:35.028575+00:00; recorded 2026-10-19T22:39:35.028575+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.